期刊文献+

缬沙坦联合贝前列素钠对高血压合并早期肾损伤患者肾功能、凝血功能以及内皮损伤的影响 被引量:19

Effect of valsartan combined with beraprost sodium on renal function,blood coagulation function and endothelial injury in patients with hypertension and early renal damage
暂未订购
导出
摘要 目的:分析缬沙坦联合贝前列素钠对高血压合并早期肾损伤患者肾功能、凝血功能以及内皮损伤的影响。方法:200例高血压合并早期肾损伤患者按照治疗方法不同,分为观察组(接受缬沙坦联合贝前列素钠治疗)97例,对照组(接受单纯缬沙坦治疗)103例,对比两组治疗后肾功能、凝血功能以及内皮损伤指标水平差异。结果:治疗后8周时,观察组血浆中胱抑素C(CysC)、β2微球蛋白(β2-MG)、纤维蛋白原(Fib)、D-二聚体(D-D)、血小板平均容积(MPV)的含量以及尿液中尿蛋白肌酐比(UACR)、α1微球蛋白(α1-MG)、N-乙酰-β-D氨基葡萄糖苷酶(NAG)的含量均显著低于对照组(P<0.05),血浆中抗凝血酶III(ATIII)含量高于对照组(P<0.05);观察组下肢动脉血流峰速(Vmax)显著高于对照组(P<0.05),颈动脉内膜中层厚度(IMT)以及下肢动脉阻力指数(RI)、血管内皮依赖性舒张功能(FMD)、血管扩张功能(NMD)均显著低于对照组(P<0.05)。结论:缬沙坦联合贝前列素钠可保护高血压合并早期肾损伤患者肾功能、避免病情进一步进展,是疾病治疗的理想方案。 Objective: To analyze the effect of valsartan combined with beraprost sodium on renal function, blood coagu- lation function and endothelial injury in patients with hypertension and early renal damage. Methods: A total of 200 patients with hypertension and early renal damage were divided into observation group (n = 97) (received valsartan combined with bera- prost sodium therapy) and control group (n = 103) (received valsartan therapy alone) according to different treatment methods. Differences in renal function, blood coagulation function and endothelial injury index levels were compared between the two groups after treatment, Results: A total of 8 weeks after treatment, cystatin C (CysC), β2-microglobulin (β2-MG), fibrinogen (Fib), D-Dimer (D-D), mean platelet volume (MPV) contents in plasma and urinary albumin ereatinine ratio (UACR), α1- MG, n-acetyl-β-d-glucosaminidase (NAG) contents in urine of observation group were significantly lower than those of control group (P〈0.05) l antithrombin Ⅲ (ATⅢ) contents in plasma were significantly higher than that of control group (P〈0.05)lower limb artery Vmax value of observation group was significantly higher than those of control group (P〈0.05) ; carotid ar- tery intima-media thickness (IMT) value lower limb artery resistance index (RI), flow-mediated dilatation (FMD) and nitro- glycerine-mediated dilatation (NMD) value were significantly lower than those of control group (P 〈0.05). Conclusions: Val- sartan combined with beraprost sodium can protect the renal function and avoid further disease progression in patients with hy- pertension and early renal damage, and it is an ideal solution to disease treatment.
作者 鱼建平
出处 《海南医学院学报》 CAS 2016年第24期2989-2992,共4页 Journal of Hainan Medical University
基金 延安大学资助项目(YD2008-45)~~
关键词 原发性高血压 肾损伤 缬沙坦 贝前列素钠 内皮功能 Primary hypertension Renal damage Valsartan Beraprost sodium Endothelial function
  • 相关文献

参考文献3

二级参考文献27

  • 1刘力生,龚兰生.中国高血压防治指南(2005年修订版)[S].北京:人民卫生出版社.2006.
  • 2雷震,刘菊先,周琛云,文晓蓉,贾浥萍,罗燕.血管回声跟踪技术对2型糖尿病患者颈动脉弹性功能的定量检测[J].中国医学影像技术,2007,23(8):1161-1163. 被引量:10
  • 3毕志军.黄芪注射液降低老年原发性高血压肾病尿蛋白含量的作用探讨[J].中西医结合心脑血管病杂志,2007,5(12):1253-1253. 被引量:7
  • 4Harrison DG,Gongora MC. Oxidative stress and hypertension[J]. Med Clin North Am, 2009,93(3) ; 621-635.
  • 5Rancourt ME,Rodrigue ME,Agharazii M, et al. Role of oxi-dative stress in erythropoie tin-induced hypertension in uremicrats [J]. Am J Hypertens? 2010,23(3) : 314-320.
  • 6Macedo E, Mehta RL. Targeting recovery from acute kidney in- jury incidence and prevalence of recovery [J]. Nephron Clin Pract,2014,127(1/2/3/4) :4-9.
  • 7Fournier JP, Sommet A, Durrieu G, et al. More on the "Triple Whammy" antihypertensive drugs, non-steroidal anti-inflamma- tory agents and acute kidney injury-a case/non-case study in the French pharmacovigilance database [J]. Ren Fail, 2014, 36 (7) .. 1166-1168.
  • 8Wang LN, Tang Z, Shou I, et al. Effects of the PGI2 analog beraprost sodium on glomerular prostanoid synthesis in rats with streptozotoein-induced diabetes[ J] Nephron, 1996, 73 ( 4 ) : 637- 643.
  • 9Jerums GJ, Campbell DJ. Long-term comparison between perin- dopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria[J ]. Am J Kidney Dis, 2001,37 (5) 890- 899.
  • 10Nozawa Y, Sato A, Piao H, et al. The effect of renal administra- tion of a selective cyclooxygenase-2 inhibitor or stable prostaglan- din Iz analog on the progression of sclerotic glomerulonephritis in rats[J]. Clin Exp Nephrol, 2012,16 (2) 221-230.

共引文献50

同被引文献169

引证文献19

二级引证文献174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部